4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-019461
Chief Financial Officer sold 10,000 shares at $8.00 ($80,000)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-02-21 | Option exercise | +10,000 | $2.90 | $29,000 | 268,870 | D |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-02-21 | Sale | −10,000 | $8.00 | $80,000 | 258,870 | D |
| Derivatives | |||||||
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-02-21 | Option exercise · Stock Option (Right to Buy) | −10,000 | 10,000 | D | ||
| Open-market sales · 10,000 sh · avg $8.00 · $80,000 | |||||||
Loading xslF345X03/tv490542_4.xml…